AS
Amy Simon
Chief Medical Officer

Amy Simon insider trades: Beam Therapeutics (BEAM) stock sales

Chief Medical Officer, Beam Therapeutics Last trade Apr 1, 2026 16 Form 4 filings
$165K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Amy reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2026BEAM↓ Sell$165K
Jul 3, 2025BEAM↓ Sell$24K
Apr 2, 2025BEAM↓ Sell$548K
Jul 2, 2024BEAM↓ Sell$29K
Apr 2, 2024BEAM↓ Sell$735K
Oct 30, 2023BEAM↓ Sell$64K
Jul 10, 2023BEAM↓ Sell10b5-1$12K
Apr 4, 2023BEAM↓ Sell$481K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BEAM insiders

Open-market trades in the last 12 months

About Amy Simon's insider trades

Amy Simon is Chief Medical Officer at Beam Therapeutics (BEAM). Since Apr 4, 2023, Amy has reported no open-market purchases and 8 sales worth $2.1M on SEC Form 4. In the last 12 months: 1 sale ($165K).

1 sale (1% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BEAM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.